Clinical Trials Logo

Filter by:
NCT ID: NCT04636229 Active, not recruiting - Knee Osteoarthritis Clinical Trials

Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Start date: December 14, 2020
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.

NCT ID: NCT04635722 Active, not recruiting - Obesity Clinical Trials

EMPOWER Weight Management

Start date: June 11, 2021
Phase: N/A
Study type: Interventional

This research is to develop a virtual weight loss and weight maintenance program through dietary modifications for adults with obesity. Although scientific studies have shown the feasibility of rapid and safe dietary weight loss and subsequent weight maintenance, no efficacious dietary weight management program is widely available, and thus bariatric surgery remains the most reliable approach for weight loss/management. Safe and effective dietary weight loss and subsequent weight maintenance require flexible, individualized advice by an experienced dietitian/nutritionist.

NCT ID: NCT04635059 Active, not recruiting - Prostate Cancer Clinical Trials

Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer

BLAST
Start date: June 1, 2021
Phase: Phase 2
Study type: Interventional

This is a single-arm, open-label study using pacritinib for patients with histologically confirmed prostate adenocarcinoma, status post definitive treatment and biochemical recurrence.

NCT ID: NCT04634877 Active, not recruiting - Clinical trials for Endometrial Neoplasms

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

Start date: January 10, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to disease-free survival (DFS) as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to overall survival (OS). The primary hypotheses are that pembrolizumab + adjuvant chemotherapy is superior to placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to DFS as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to OS.

NCT ID: NCT04634617 Active, not recruiting - Clinical trials for Endometrial Carcinoma

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Start date: January 9, 2020
Phase:
Study type: Observational

This trial studies pelvic floor dysfunction and quality of life in uterine cancer survivors. Using questionnaires may help researchers learn more about the sexual function and quality of life in uterine cancer survivors.

NCT ID: NCT04634539 Active, not recruiting - Pancreatic Cancer Clinical Trials

Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer

Start date: May 13, 2021
Phase: Phase 1
Study type: Interventional

This study will enroll a total of 16 patients with advanced pancreatic cancer at Cedars-Sinai Medical Center. All subjects will receive combination therapy of gemcitabine, nab-paclitaxel, and L-glutamine. The study investigates what the appropriate dosage of L-glutamine is so that there is the lowest risk of side effects, and whether the supplement will make standard chemotherapy of gemcitabine and nab-paclitaxel more effective in treating advanced pancreatic cancer.

NCT ID: NCT04634513 Active, not recruiting - Shigella Infection Clinical Trials

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Start date: September 29, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether a live, oral, combined Shigella-ETEC vaccine candidate, known as strain CVD 1208S-122, is safe and immunogenic.

NCT ID: NCT04634279 Active, not recruiting - Depression Clinical Trials

Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses

Start date: August 31, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and then test an enhanced version of the parent study's collaborative care intervention for co-occurring disorders (CC-COD) to reduce the risk of suicide and overdose among individuals with opioid use disorder (OUD) in combination with PTSD/depression. The parent study is CLARO, Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (NCT04559893).

NCT ID: NCT04634084 Active, not recruiting - Clinical trials for Rotator Cuff Injuries

Subacromial Bursa Re-Implantation After Rotator Cuff Repair

Start date: March 24, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate clinical outcomes, structural integrity, and tendon organization after rotator cuff repair with and without subacromial bursa implantation and to further co-existing research studies performed at The University Of Texas Health Science Center of Houston (UT Health) on Ultrashort Time to Echo-Magnetic Imaging Resonance(UTE-MRI) techniques and their implication for rotator cuff analysis.

NCT ID: NCT04633824 Active, not recruiting - Pain Clinical Trials

Health Disparities on the Labor Floor

Start date: February 1, 2021
Phase:
Study type: Observational

The Agency for Healthcare Research and Quality (AHRQ) defines a disparity as a difference or a gap that exist between two groups, which is both statistically significant, larger than 10%, and indicates poor quality for the minority (non-referent) group. Despite advances in public health initiatives and medicine, disparities in healthcare are persistent. For example, in the United States, maternal mortality ratio has doubled since 1987 to 2009 where African American women were 4 times as likely to die from childbirth. Although there was no observed racial disparity in maternal deaths at University of Alabama Birmingham, there is anecdotal experience that may suggest health disparities do exist on the labor floor when examining neuraxial utilization and effectiveness. This retrospective study will seek to examine the successful extension of labor analgesia for cesarean section as it relates to insurance status.